126 results
Page 4 of 7
6-K
EX-99.1
dsb6x fc8pmo
6 Feb 14
Teva Reports Fourth Quarter and Full Year 2013 Results
12:00am
6-K
EX-99.1
g9sl6t
29 Jan 14
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE® (glatiramer acetate injection) 40mg/mL
12:00am
6-K
EX-99.1
lcna4
24 Jan 14
Live Filing
12:00am
6-K
EX-99.1
r7dr5dpo
13 Jan 14
Live Filing
12:00am
6-K
EX-99.1
6xfs kzwr
9 Jan 14
Teva Names Erez Vigodman as President and CEO
12:00am
6-K
EX-99.1
32rxtr c1w84
3 Jan 14
Live Filing
12:00am
6-K
EX-99.1
plu34mjhwl khalq07o
17 Dec 13
Teva Settles Viagra® Patent Litigation with Pfizer
12:00am
6-K
EX-99.1
1sybi8yardw1x26ascz
10 Dec 13
Live Filing
12:00am
6-K
EX-99.1
65ncbceee8 epsojuu
10 Dec 13
Teva Provides 2014 Non-GAAP Financial Outlook
12:00am
6-K
EX-99.1
nt0dpt9r
4 Dec 13
Teva and Takeda Announce Development and Distribution Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
12:00am
6-K
EX-99.1
pb65b
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
3jv272wc
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
t7f3tz4b8
27 Nov 13
Teva Announces Additional Regulatory Exclusivity for Treanda® (Bendamustine Hci) for Injection
12:00am
6-K
EX-99.1
bh38j49ukil ft06j
25 Nov 13
Teva and Mylan Settle Copaxone® Patent Litigation In France, the Uk and the Netherlands
12:00am
6-K
EX-99.1
igpxg9sj4b c43
25 Nov 13
Live Filing
12:00am
6-K
EX-99.1
b2ivvy2a1d6owbiimxim
19 Nov 13
Live Filing
12:00am
6-K
EX-99.1
368vdzg8sn1hsseka8r
18 Nov 13
Teva Announces Updates to Oncology Biologic Portfolio
12:00am